*

Featured Post

Nutrition and Hormonal Balance

  Good Morning,  Nutrition and Hormonal Balance As an acupuncturist in the area of fertility, I realize tha...

Subscribe Updates via email

Subscribe Updates via email

Enter your email address:

Friday, April 15, 2011

[AlternativeAnswers] A prospective study on the role of CXCL13 in Lyme neuroborreliosis.

 




Neurology. 2011 Mar 22;76(12):1051-8.

A prospective study on the role of CXCL13 in Lyme neuroborreliosis.

Schmidt C, Plate A, Angele B, Pfister HW, Wick M, Koedel U, Rupprecht TA.

Department of Neurology, Amper Kliniken AG, Krankenhausstr. 15, 85221
Dachau, Germany _mail@dr-tobias-rupprecht.de_
(mailto:mail@dr-tobias-rupprecht.de) .

Abstract

BACKGROUND: The definite diagnosis of acute Lyme neuroborreliosis (LNB)
requires detection of an increased Borrelia burgdorferi-specific
antibody index (AI). The B burgdorferi AI, however, is negative in up to
20% of patients with early LNB and can remain elevated for years after
adequate therapy; both of these factors can make the diagnosis
difficult. Recent retrospective studies suggested the chemokine CXCL13
as a potential biomarker for LNB. To evaluate its diagnostic value, we
conducted a prospective study.

METHODS: From March 2008 to August 2009, CSF and serum samples from all
patients in whom a B burgdorferi-specific AI was requested (n = 692) and
CSF analysis revealed CSF pleocytosis (n = 192) were included in the
study. Because of the low number of patients with untreated LNB, 13
additional retrospectively selected samples of patients with untreated
LNB were added. CXCL13 concentrations were measured by ELISA and
receiver operating characteristic curves were generated.

RESULTS: CSF CXCL13 was highly elevated in all patients with untreated
acute LNB (mean = 15,149 pg/mL) compared with that in the patients
without LNB (mean = 247 pg/mL). At a cutoff of 1,229 pg/mL, the
sensitivity of CXCL13 was 94.1%, which is higher than the AI (85.7%).
Only 7 patients (5 with a CNS lymphoma and 2 with bacterial meningitis)
had a CXCL13 level above the cutoff, resulting in a specificity equal to
the AI of 96.1%.

CONCLUSIONS: CXCL13 shows high sensitivity and specificity for acute,
untreated LNB. This novel marker appears to be helpful in clinically
atypical cases and, in particular, in early stages of the disease when
the B burgdorferi AI is (still) negative.

PMID: 21422457 [PubMed - in process]

[Non-text portions of this message have been removed]

__._,_.___
Recent Activity:
*********************************************
Peacefulmind.com Sponsors Alternative Answers-

HEALING NATURALLY- Learn preventative and curative measure to take for many ailments at:

http://www.peacefulmind.com/ailments.htm
____________________________________________

-To INVITE A FRIEND to our healing community, copy and paste this address in an email to them:

http://health.groups.yahoo.com/group/AlternativeAnswers/subs_invite

___________________________________________
To ADD A LINK, RESOURCE, OR WEBSITE to Alternative Answers please Go to:

http://health.groups.yahoo.com/group/AlternativeAnswers/links

_____________________________________________
Community email addresses:
  Post message: AlternativeAnswers@yahoogroups.com
  Subscribe:    AlternativeAnswers-subscribe@yahoogroups.com
  Unsubscribe:  AlternativeAnswers-unsubscribe@yahoogroups.com
  List owner:   AlternativeAnswers-owner@yahoogroups.com
_________________________________________
Shortcut URL to this page:
  http://health.groups.yahoo.com/group/AlternativeAnswers
.

__,_._,___
Post a Comment